Home / Services / Genetic Engineering and Gene Editing / CRISPR-based Gene Editing Services / CRISPR/Cas9 Off-Target Screening Service

CRISPR/Cas9 Off-Target Screening Service

Online Inquiry

CRISPR/Cas9 off-target screening services provide a crucial step in ensuring the precision and safety of CRISPR/Cas9 gene-editing experiments. Off-target effects, where the CRISPR/Cas9 system makes unintended modifications in the genome, can lead to undesired mutations and potential adverse effects. Our off-target screening services utilize advanced techniques to detect and minimize these unintended edits, ensuring the highest accuracy and reliability in your gene-editing projects.

Off-target detection using nuclease-induced toxicity (DW Morgens, et al.,2017)

Overview Service Process Examples and Solutions Applications Frequently Asked Questions


CRISPR/Cas9 off-target screening involves the identification and analysis of unintended genomic modifications that may occur during CRISPR/Cas9-mediated gene editing. This service employs comprehensive and sensitive detection methods, such as high-throughput sequencing and bioinformatics analysis, to map off-target sites and quantify their occurrence. By pinpointing off-target effects, researchers can refine their CRISPR/Cas9 designs to enhance specificity and reduce potential risks.

Service Process

The process of CRISPR/Cas9 off-target screening involves several critical and interrelated steps:

  1. Guide RNA Design: Optimizing gRNA sequences to enhance specificity and reduce off-target potential. This initial step is crucial for minimizing unintended edits.
  2. Cell Preparation and Transfection: Introducing CRISPR/Cas9 components into target cells under controlled conditions.
  3. DNA Extraction: Isolating genomic DNA from the edited cells for subsequent analysis.
  4. Off-Target Detection: Employing high-throughput sequencing techniques, such as GUIDE-seq, SITE-seq, or Digenome-seq, to identify potential off-target sites across the genome.
  5. Bioinformatics Analysis: Analyzing sequencing data using advanced bioinformatics tools to map and quantify off-target effects. This step involves comparing the genomic sequences of edited and unedited cells to pinpoint unintended modifications.
  6. Validation and Reporting: Validating detected off-target sites through additional methods, such as targeted deep sequencing or qPCR, and providing a comprehensive report detailing the findings and recommendations.

For more information about our CRISPR/Cas9 Off-Target Screening Services or to discuss your specific needs, please contact us. Our team of experts is available to provide guidance and support for your research projects, ensuring you achieve your scientific and therapeutic goals.

Examples and Solutions

The following table provides an overview of various case studies in CRISPR/Cas9 off-target screening and the solutions we offer to support your research and therapeutic endeavors:

Case Study Description Solutions We Offer
Gene Therapy Safety Assessment Identifying off-target effects in gene therapy applications to ensure safety. GUIDE-seq analysis, validation assays, and comprehensive reporting.
Cancer Research Screening for off-target mutations in CRISPR-edited cancer cell lines. SITE-seq detection, bioinformatics analysis, and targeted sequencing.
Agricultural Biotechnology Ensuring precision in CRISPR-modified crops and livestock. Digenome-seq screening, off-target mapping, and trait analysis.
Neurodegenerative Disease Studies Detecting off-target effects in CRISPR models of neurodegenerative diseases. GUIDE-seq and SITE-seq integration, functional assays, and data interpretation.
Drug Target Validation Verifying specificity of CRISPR screens in drug development. Comprehensive off-target profiling, bioinformatics support, and validation.


The applications of CRISPR/Cas9 off-target screening are essential across various fields, including:

  • Gene Therapy Development: Ensuring the safety and efficacy of CRISPR-based therapies by minimizing off-target effects.
  • Functional Genomics: Improving the accuracy of gene function studies by identifying and eliminating off-target edits.
  • Drug Development: Enhancing the reliability of CRISPR/Cas9 screens used for drug target identification and validation.
  • Agricultural Biotechnology: Ensuring the precision of genetic modifications in crops and livestock to prevent unintended consequences.
  • Basic Research: Providing accurate data for fundamental research involving gene editing.

Frequently Asked Questions

Q: What is CRISPR/Cas9 off-target screening?

A: CRISPR/Cas9 off-target screening involves detecting and analyzing unintended genomic modifications that may occur during CRISPR/Cas9-mediated gene editing. This service ensures the precision and safety of gene-editing experiments by identifying and quantifying off-target effects.

Q: How is CRISPR/Cas9 off-target screening performed?

A: Off-target screening is performed using high-throughput sequencing techniques, such as GUIDE-seq, SITE-seq, or Digenome-seq, followed by bioinformatics analysis to map and quantify off-target sites. Validation is conducted through additional sequencing or qPCR methods.

Q: What are the applications of CRISPR/Cas9 off-target screening?

A: Applications include gene therapy development, functional genomics, drug development, agricultural biotechnology, and basic research. Off-target screening enhances the accuracy and safety of CRISPR/Cas9 gene editing across various fields.

Q: What are the key steps in the CRISPR/Cas9 off-target screening process?

A: Key steps include guide RNA design, cell preparation and transfection, DNA extraction, off-target detection using high-throughput sequencing, bioinformatics analysis, and validation and reporting of off-target effects.

Q: Why is CRISPR/Cas9 off-target screening important?

A: Off-target screening is crucial for ensuring the precision and safety of CRISPR/Cas9 gene-editing experiments. It helps identify unintended modifications, allowing researchers to refine their editing strategies and minimize potential risks.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.


There is no product in your cart.